Filana Therapeutics
FLNA
152 hedge funds and large institutions have $287M invested in Filana Therapeutics in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 12 closing their positions.
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
5% more funds holding
Funds holding: 145 → 152 (+7)
10% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 41
7% more call options, than puts
Call options by funds: $44.4M | Put options by funds: $41.4M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.65% less ownership
Funds ownership: 28.68% → 28.02% (-0.65%)
1% less capital invested
Capital invested by funds: $291M → $287M (-$4.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.99M |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$1.11M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.07M |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$827K |
| 5 |
Squarepoint
New York
|
+$789K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.71M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.57M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.65M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.45M |
| 5 |
TC
TwinBeech Capital
Purchase,
New York
|
-$1.38M |
FLNA Hedge Fund Activity: Q2 2023 in Review
152 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2023, worth a combined $287M — down 1.5% from $291M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new FLNA positions and 12 closed out — a net gain of 7 holders — while 45 added to existing stakes and 41 trimmed.
The largest buyer was BlackRock, adding an estimated $2.99M. The largest seller was Invesco, cutting an estimated $6.71M.
- 152 institutional investors held Filana Therapeutics (FLNA) as of Q2 2023, up from 145 in Q1 2023.
- Funds reported $287M of Filana Therapeutics stock for Q2 2023, down 1.5% quarter-over-quarter.
- 19 funds opened new Filana Therapeutics positions in Q2 2023 and 12 closed out, a net change of +7 holders.
- The largest Filana Therapeutics buyer in Q2 2023 was BlackRock, an estimated $2.99M added.
- The largest Filana Therapeutics seller in Q2 2023 was Invesco, an estimated $6.71M sold.
Based on aggregated 13F filings for Q2 2023.